Peptide Innovation in Kidney Care

🧬 New Publication Release!

We are proud to present our latest peer-reviewed article in the American Journal of Biomedical Science & Research:

Emerging Peptide Therapies for Kidney Disease: Focus on Nano-Organo and Mitochondria-Targeted Strategies
By Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, and Prof. Jonathan R.T. Lakey

💡 What’s Inside?
This cutting-edge review explores two next-generation peptide platforms: Nano-Organo Peptides (NOPs) and Mitochondria-Targeted Peptides (MTPs) as precision therapies for Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD).

📌 Key Highlights:
✔️ Nano-Organo Peptides (NOPs): Deliver peptides to subcellular compartments (e.g., mitochondria, lysosomes, ER) for targeted renal repair
✔️ Mitochondria-Targeted Peptides (MTPs): Protect kidney mitochondria by stabilizing cardiolipin, reducing oxidative stress, and restoring bioenergetics
✔️ Promising results in fibrosis attenuation, immune modulation, glomerular protection, and tubular cell survival
✔️ Therapeutic examples like SS-31 (elamipretide) show effectiveness in ischemia-reperfusion injury, diabetic nephropathy, and age-related renal decline
✔️ Highlights early clinical studies, renal-targeted delivery strategies, and emerging precision nephrology applications

This review outlines the scientific rationale, delivery systems, mechanistic targets, and clinical potential of peptide-based therapeutics in nephrology, opening new pathways for overcoming the limitations of conventional kidney treatments.

WATCH THE REEL
https://youtube.com/shorts/xUTD28-bTTA

📖 Learn more about the publication here:
🔗 https://european-wellness.eu/publications/emerging-peptide-therapies/

📖 Full Access:
🔗 https://biomedgrid.com/pdf/AJBSR.MS.ID.003551.pdf

📖 More publications here:
🔗 https://european-wellness.eu/publications/